Elanco Animal Health Incorporated

NYSE:ELAN 株式レポート

時価総額:US$6.6b

Elanco Animal Health 過去の業績

過去 基準チェック /26

Elanco Animal Healthの収益は年間平均-30.1%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間1.2% 8.2%割合で 増加しています。 Elanco Animal Healthの自己資本利益率は3.1%であり、純利益率は4.6%です。

主要情報

-30.1%

収益成長率

-28.7%

EPS成長率

Pharmaceuticals 業界の成長6.0%
収益成長率8.2%
株主資本利益率3.1%
ネット・マージン4.6%
前回の決算情報30 Sep 2024

最近の業績更新

Elanco Animal Health's (NYSE:ELAN) Solid Profits Have Weak Fundamentals

Nov 15
Elanco Animal Health's (NYSE:ELAN) Solid Profits Have Weak Fundamentals

Recent updates

Elanco Animal Health's (NYSE:ELAN) Solid Profits Have Weak Fundamentals

Nov 15
Elanco Animal Health's (NYSE:ELAN) Solid Profits Have Weak Fundamentals

Elanco Animal Health: Not Expensive, But Debt Remains An Issue

Nov 08

Here's Why Elanco Animal Health (NYSE:ELAN) Has A Meaningful Debt Burden

Sep 22
Here's Why Elanco Animal Health (NYSE:ELAN) Has A Meaningful Debt Burden

Elanco Animal Health Incorporated (NYSE:ELAN) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Sep 01
Elanco Animal Health Incorporated (NYSE:ELAN) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Elanco Animal Health: Positioned For Success

Aug 16

Investors Don't See Light At End Of Elanco Animal Health Incorporated's (NYSE:ELAN) Tunnel And Push Stock Down 27%

Jul 11
Investors Don't See Light At End Of Elanco Animal Health Incorporated's (NYSE:ELAN) Tunnel And Push Stock Down 27%

Elanco Animal Health: Pipeline Concerns Appear Overblown

Jun 30

Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Jun 06
Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Elanco Animal Health: At Least Fully Valued After Rally

Jun 05

Benign Growth For Elanco Animal Health Incorporated (NYSE:ELAN) Underpins Its Share Price

Apr 22
Benign Growth For Elanco Animal Health Incorporated (NYSE:ELAN) Underpins Its Share Price

Elanco Animal Health (NYSE:ELAN) Seems To Be Using A Lot Of Debt

Feb 24
Elanco Animal Health (NYSE:ELAN) Seems To Be Using A Lot Of Debt

Elanco Animal Health: A Solid Sale Addresses Leverage

Feb 09

Elanco Animal Health Incorporated (NYSE:ELAN) Looks Inexpensive But Perhaps Not Attractive Enough

Jan 01
Elanco Animal Health Incorporated (NYSE:ELAN) Looks Inexpensive But Perhaps Not Attractive Enough

Elanco Animal Health: Turning More Healthy

Dec 21

Is Elanco Animal Health (NYSE:ELAN) A Risky Investment?

Nov 09
Is Elanco Animal Health (NYSE:ELAN) A Risky Investment?

Elanco Animal Health: Signs Of Stabilization, Amidst Still A Big Debt Pile

Oct 05

Here's Why Elanco Animal Health (NYSE:ELAN) Is Weighed Down By Its Debt Load

Aug 02
Here's Why Elanco Animal Health (NYSE:ELAN) Is Weighed Down By Its Debt Load

Elanco Animal Health: Seems Like A Decent Bet Right Now

Jul 25

Elanco Animal Health: Robust Results Overshadowed By Persisting Challenges

Jul 14

There's No Escaping Elanco Animal Health Incorporated's (NYSE:ELAN) Muted Revenues

Jun 09
There's No Escaping Elanco Animal Health Incorporated's (NYSE:ELAN) Muted Revenues

Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Feb 22
Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Elanco Q4 2022 Earnings Preview

Feb 20

Elanco's Tangible Equity Units: Living With The Worst Case

Dec 13

We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

Nov 08
We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

Elanco Q3 2022 Earnings Preview

Nov 07

Elanco Animal Health: This 'Sick Dog' Should Recover

Oct 19

収支内訳

Elanco Animal Health の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NYSE:ELAN 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Sep 244,4542051,301342
30 Jun 244,492-1,2551,291341
31 Mar 244,365-1,3021,290333
31 Dec 234,417-1,2311,280327
30 Sep 234,367-1,1441,289328
30 Jun 234,324-1131,273320
31 Mar 234,442-261,263321
31 Dec 224,411-781,259321
30 Sep 224,538-1321,290333
30 Jun 224,644-1711,334349
31 Mar 224,748-3711,372361
31 Dec 214,764-4831,395369
30 Sep 214,791-6981,431390
30 Jun 214,550-7291,373384
31 Mar 213,857-5721,153349
31 Dec 203,271-574988329
30 Sep 202,921-246810281
30 Jun 202,802-101719263
31 Mar 202,998-13759273
31 Dec 193,07168757270
30 Sep 193,08394759264
30 Jun 193,073144746253
31 Mar 193,06245736246
31 Dec 183,06787735247
30 Sep 183,022-91747248
30 Jun 182,958-172763250
31 Mar 182,906-174766253
31 Dec 172,889-311780252
31 Dec 162,914-48785266
31 Dec 152,909-211916291

質の高い収益: ELANには$436.5M } という大きな 一回限りの 利益があり、過去 12 か月の財務実績が30th September, 2024に影響を及ぼしています。

利益率の向上: ELAN過去に利益を上げました。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: ELAN過去 5 年間で収益を上げており、収益は年間-30.1%増加しています。

成長の加速: ELANは昨年収益を上げたため、収益成長率を 5 年間の平均と比較することは困難です。

収益対業界: ELAN昨年収益を上げたため、昨年の収益成長をPharmaceuticals業界 ( 54.6% ) と比較することは困難です。


株主資本利益率

高いROE: ELANの 自己資本利益率 ( 3.1% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘